EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Left Atrial Appendage Occlusion in Patients With Prior Gastrointestinal Bleeds

Douglas Darden, Aashish Katapadi, Chien Yu Huang, Sarah Zimmerman, Dhanunjaya Lakkireddy, Rajesh Kabra, Naga Venkata K Pothineni, Rakesh Gopinathannair, Muhammad Bilal Munir, James V Freeman, Jonathan C Hsu

JACC: Clinical Electrophysiology · 2026-01 · 12 (1) · 119-130

DOI: 10.1016/j.jacep.2025.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-01. Verfasst von Douglas Darden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA. Electronic address: dardendoug@gmail.com. Hauptthemen laut MEDLINE: Atrial Appendage, Gastrointestinal Hemorrhage, Atrial Fibrillation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left atrial appendage occlusion (LAAO) is increasingly used as a stroke prevention strategy in patients with atrial fibrillation who have contraindications to oral anticoagulation, including prior gastrointestinal bleeding (GIB). However, the clinical risks and benefits of LAAO may differ substantially depending on the specific indication for the procedure, and outcomes in patients with prior GIB remain incompletely understood. OBJECTIVES: The aim of this study was to evaluate in-hospital and long-term outcomes of LAAO in patients with prior GIB. METHODS: Using data from the National Cardiovascular Data Registry LAAO Registry, patients who underwent Watchman LAAO between January 2016 and December 2022 were analyzed. In-hospital and long-term adverse events, mortality, and postimplantation antithrombotic prescriptions were compared between patients with and those without prior GIB. RESULTS: Prior GIB was common (33.7%) in patients undergoing Watchman LAAO. These patients were older, had more comorbidities, and often underwent Watchman 2.5 (31.4% vs 41.3%) vs Watchman FLX (68.6% vs 58.7%) implantation than their non-GIB counterparts. After adjustment, prior GIB was associated with higher rates of in-hospital major complications (OR: 1.18; 95% CI: 1.10-1.26). At 45 days, these patients had increased risks for GIB (HR: 4.36; 95% CI: 4.07-4.66) and major bleeding (HR: 2.94; 95% CI: 2.74-3.16). At 1-year follow-up, they remained at significantly higher risk for GIB (HR: 3.84; 95% CI: 3.65-4.03), major bleeding (HR: 2.82; 95% CI: 2.67-2.98), and death (HR: 1.10; 95% CI: 1.06-1.14). Stroke risk was no different between groups. Overall, those with GIB were more likely to receive conservative postprocedural antithrombotic regimens, including higher rates of no antithrombotic agents, warfarin only, and dual antiplatelet therapy. CONCLUSIONS: Patients with prior GIB undergoing LAAO experienced higher in-hospital complications and long-term risks for GIB and major bleeding, with no differences in stroke risk. This underscores the need for improved postprocedural strategies to mitigate bleeding risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageGastrointestinal HemorrhageAtrial FibrillationHumansFemaleMaleAgedStrokeRegistriesAged, 80 and overTreatment OutcomeMiddle AgedAnticoagulants

Stichwörter der Autor:innen

atrial fibrillationgastrointestinal bleedleft atrial appendage occlusionoral anticoagulation

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA. Electronic address: dardendoug@gmail.com.
  • Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.
  • Center for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, Connecticut, USA.
  • University of California-San Diego Health, San Diego, California, USA.
  • Center for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, Connecticut, USA; University of California-Davis, Sacramento, California, USA.
  • University of California-Davis, Sacramento, California, USA.

Zitieren

APA

Darden, D., Katapadi, A., Huang, C. Y., Zimmerman, S., Lakkireddy, D., Kabra, R., Pothineni, N. V. K., Gopinathannair, R., Munir, M. B., Freeman, J. V., & Hsu, J. C. (2026). Outcomes of Left Atrial Appendage Occlusion in Patients With Prior Gastrointestinal Bleeds. JACC: Clinical Electrophysiology, 12(1), 119-130. https://doi.org/10.1016/j.jacep.2025.09.009

Vancouver

Darden D, Katapadi A, Huang CY, Zimmerman S, Lakkireddy D, Kabra R, et al. Outcomes of Left Atrial Appendage Occlusion in Patients With Prior Gastrointestinal Bleeds. JACC: Clinical Electrophysiology. 2026;12(1):119-130. doi:10.1016/j.jacep.2025.09.009

BibTeX
@article{Darden2026,
  author = {Darden, Douglas and Katapadi, Aashish and Huang, Chien Yu and Zimmerman, Sarah and Lakkireddy, Dhanunjaya and Kabra, Rajesh and Pothineni, Naga Venkata K and Gopinathannair, Rakesh and Munir, Muhammad Bilal and Freeman, James V and Hsu, Jonathan C},
  title = {Outcomes of Left Atrial Appendage Occlusion in Patients With Prior Gastrointestinal Bleeds},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {119--130},
  doi = {10.1016/j.jacep.2025.09.009}
}
Kostenlos starten →